Medifast, Inc. (MED) Misses Q3 EPS by 1c, Sales Fall Short
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.90 -0.42%
EPS Growth %: -195.2%
Financial Fact:
Revenue: 68.58M
Today's EPS Names:
LGCY, UXIN, SCHL, More
EPS Growth %: -195.2%
Financial Fact:
Revenue: 68.58M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q3 EPS of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $76.1 million versus the consensus estimate of $78.89 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- Cintas beats estimates but stock edges lower
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
